Financials data is unavailable for this security.
View more
Year on year Unichem Laboratories Ltd grew revenues 26.94% from 13.43bn to 17.05bn. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -2.02bn to -704.74m.
| Gross margin | 62.00% |
|---|---|
| Net profit margin | -3.50% |
| Operating margin | -3.35% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, cash reserves at Unichem Laboratories Ltd fell by 328.40m. However, Cash Flow from Investing totalled 504.04m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 166.94m in cash from operations while cash used for financing totalled 1.06bn.
| Cash flow per share | 7.41 |
|---|---|
| Price/Cash flow per share | 118.19 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 65.15%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 66.29 |
